Quantitative proteomic profiling identifies new renal targets of copper(II)-selective chelation in the reversal of diabetic nephropathy in rats

Proteomics

Volumn 9, Issue 18, 2009, Pages 4309-4320

  Gong, Deming ^a   Chen, Xiuyin ^a   Middleditch, Martin ^b   Huang, Liangdong ^a   Amarsingh, Greeshma Vazhoor ^a   Reddy, Shiva ^a   Lu, Jun ^a   Zhang, Shaoping ^a,b   Ruggiero, Katya ^a   Phillips, Anthony R J ^a,b,c   Cooper, Garth J S ^a,b,d  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Animal proteomics; Diabetic nephropathy; iTRAQ ; Kidney; Triethylenetetramine

Indexed keywords

ACTININ; ACTININ 4ALPHA; ANTIGEN; APOPTOSIS INDUCING FACTOR; APOPTOSIS INDUCING FACTOR 1; AQUAPORIN 1; COLLAGEN 6ALPHA1; COLLAGEN TYPE 6; COPPER ZINC SUPEROXIDE DISMUTASE; CUPRIC ION; CYTOCHROME C; DEXTRO AMINO ACID OXIDASE; DEXTRO AMINO ACID OXIDASE 1; EPOXIDE HYDROLASE; EPOXIDE HYDROLASE 1; GLUTATHIONE TRANSFERASE A3; HEAT SHOCK PROTEIN 60; HISTONE H3; TRIENTINE; TUBULOINTERSTITIAL NEPHRITIS ANTIGEN; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL 1; VOLTAGE DEPENDENT ANION CHANNEL 2;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL LABELING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; KIDNEY HYPERTROPHY; KIDNEY MASS; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; PROTEOMICS; RAT; STREPTOZOCIN DIABETES; UPREGULATION;

ANIMALS; CATIONS; CELL ADHESION MOLECULES; CHELATING AGENTS; COLLAGEN TYPE VI; COPPER; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DOWN-REGULATION; GLUTATHIONE PEROXIDASE; IMMUNOHISTOCHEMISTRY; MALE; NEPHRITIS, INTERSTITIAL; PROTEOMICS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; TRIETHYLENETETRAMINE; UP-REGULATION;

ANIMALIA; RATTUS;

EID: 70349088195     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200900285     Document Type: Article

References (40)

1. Friedman, E. A., Friedman, A. L., Is there really good news about pandemic diabetic nephropathy? Nephrol. Dia. Transplant. 2007, 22, 681-683.
2. Susztak, K., Raff, A. C., Schiffer, M., Bottinger, E. P., Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 2006, 55, 225-233. (Pubitemid 43343319)
3. Thongboonkerd, V., Barati, M. T., McLeish, K. R., Benarafa, C. et al., Alterations in the renal elastin-elastase system in type 1 diabetic nephropathy identified by proteomic analysis. J. Am. Soc. Nephrol. 2004, 15, 650-662. (Pubitemid 38294795)
4. Knoll, K. E., Pietrusz, J. L., Liang, M., Tissue-specific transcriptome responses in rats with early streptozotocin-induced diabetes. Physiol. Genomics 2005, 21, 222-229. (Pubitemid 40898482)
5. Wilson, K. H. S., Eckenrode, S. E., Li, Q.-Z., Ruan, Q. G. et al., Microarray analysis of gene expression in the kidneys of new- and post-onset diabetic NOD mice. Diabetes 2003, 52, 2151-2159.
6. Cheng, D. W., Jiang, Y., Shalev, A., Kowluru, R. et al., An analysis of high glucose and glucosamine-induced gene expression and oxidative stress in renal mesangial cells. Arch. Physiol. Biochem. 2006, 112, 189-218. (Pubitemid 46018362)
7. Sharma, K., Han, D. C., Mogyorosi, A., Ziyadeh, F. N. (Eds.), Structural and functional consequences of streptozotocin-induced diabetes on the kidney. In: McNeill J. H. (Ed.), Experimental Models of Diabetes, CRC, Boca Raton, FL 1999, pp. 39-62.
8. Liu, D., Razzaque, M. S., Cheng, M., Taguchi, T., The renal expression of heat shock protein 47 and collagens in acute and chronic experimental diabetes in rats. Histochem. J. 2001, 33, 621-628. (Pubitemid 34852230)
9. Tesch, G. H., Allen, T. J., Rodent models of streptozotocin-induced diabetic nephropathy. Nephrol. 2007, 12, 261-266.
10. Gong, D., Lu, J., Chen, X., Choong, S. Y. et al., Molecular changes evoked by triethylenetetramine (TETA) of extracellular matrix in the heart and aorta of diabetic rats. Mol. Pharmacol. 2006, 70, 2045-2051. (Pubitemid 44771920)
11. Gong, D., Lu, J., Chen, X., Reddy, S. et al., A copper (II)-selective chelator ameliorates diabetes-evoked renal fibrosis and albuminuria, and suppresses pathogenic TGF-β activation in the kidneys of rats used as a model of diabetes. Diabetologia 2008, 51, 1741-1751.
12. Vidotti, D. B., Arnoni, C. P., Maquigussa, E., Boim, M. A., Effect of long-term type 1 diabetes on renal sodium and water transporters in rats. Am. J. Nephrol. 2008, 28, 107-114. (Pubitemid 350126500)
13. Verman, A. S., Roles of aquaporins in kidney revealed by transgenic mice. Semin. Nephrology 2006, 26, 200-208.
14. Gallego, M., Fernandez, D., Ahyayauch, H., Casis, E., Casis, O., Reduced calmodulin expression accelerates transient outward potassium current inactivation in diabetic rat heart. Cell. Physio. Biochem. 2008, 22, 625-634.
15. Williams, R. E., Lock, E. A., Sodium benzoate attenuates D-serine-induced nephrotoxicity in the rat. Toxicology 2005, 207, 35-48. (Pubitemid 39601684)
16. Thomas, H., Schladt, L., Knehr, M., Oesch, F., Effect of diabetes and starvation on the activity of rat liver epoxide hydrolases, glutathione S-transferases and peroxisomal beta-oxidation. Biochem. Pharmacol. 1989, 38, 4291-4297. (Pubitemid 20009029)
17. Imig, J. D., Eicosanoid regulation of the renal vasculature. Am. J. Physiol. Renal Physiol. 2000, 279, F965-F981.
18. Olearczyk, J. J., Quigley, J. E., Mitchell, B. C., Yamamoto, T. et al., Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats. Clin. Sci. 2009, 116, 61-70.
19. Li, J., Carroll, M. A., Chander, P. N., Falck, J. R. et al., Soluble epoxide hydrolase inhibitor, AUDA, prevents early salt-sensitive hypertension. Front. Biosci. 2008, 13, 3480-3487. (Pubitemid 351594697)
20. Imig, J. D., Zhao, X., Zaharis, C. Z., Olearczyk, J. J. et al., An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension. Hypertension 2005, 46, 975-981.
21. Jullig, M., Chen, X., Hickey, A. J., Crossman, C. et al., Reversal of diabetes-evoked changes in mitochondrial protein expression of cardiac left ventricle by treatment with a copper(II)-selective chelator. Proteomics Clin. Appl. 2007, 1, 387-399.
22. Jullig, M., Hickey, A. J., Middleditch, M. J., Crossman, D. J., Cooper, G. J. S., Characterization of proteomic changes in cardiac mitochondria in streptozotocin-diabetic rats using iTRAQ isobaric tags. Proteomics Clin. Appl. 2007, 1, 565-576.
23. Shan, Y. X., Yang, T. L., Mestril, R., Wang, P. H., HSP10 and HSP60 suppress ubiquitination of insulin-like growth factor-1 receptor and augment insulin-like growth factor-1 receptor signaling in cardiac muscle: implications on decreased myocardial protection in diabetic cardiomyopathy. J. Biol. Chem. 2003, 278, 45492-45498. (Pubitemid 37432688)
24. Chen, H. S., Shan, Y. X., Yang, T. L., Lin, H. D. et al., Insulin deficiency downregulated heat shock protein 60 and IGF-1 receptor signaling in diabetic myocardium. Diabetes 2005, 54, 175-181.
25. Huurman, V. A., van der Meide, P. E., Duinkerken, G., Willemen, S. et al., Immunological efficacy of heat shock protein 60 peptide DiaPep277 therapy in clinical type I diabetes. Clin. Exp. Immunol. 2008, 152, 488-497. (Pubitemid 351661507)
26. Lin, Y., Berg, A. H., Iyengar, P., Lam, T. K. et al., The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. J. Biol. Chem. 2005, 280, 4617-4626. (Pubitemid 40288630)
27. Zhang, Y., Wada, J., Hashimoto, I., Eguchi, J. et al., Therapeutic approach for diabetic nephropathy using gene delivery of translocase of inner mitochondrial membrane 44 by reducing mitochondrial superoxide production. J. Am. Soc. Nephrol. 2006, 17, 1090-1101.
28. Ha, H., Hwang, I. A., Park, J. H., Lee, H. B., Role of reactive oxygen species in the pathogenesis of diabetic nephropathy. Diabetes Res. Clin. Practice 2008, 82, S42-S45.
29. Nerlich, A. G., Schleicher, E. D., Wiest, I., Specks, U., Timpl, R., Immunohistochemical localization of collagen VI in diabetic glomeruli. Kidney Int. 1994, 45, 1648-1656. (Pubitemid 24207500)
30. Mohan, P. S., Carter, W. G., Spiro, R. G., Occurrence of type VI collagen in extracellular matrix of renal glomeruli and its increase in diabetes. Diabetes 1990, 39, 31-37.
31. Delahunt, B., Stehbens,W. E., Gilbert-Barness, E., Shozawa, T., Ruger, B. M., Progeria kidney has abnormal mesangial collagen distribution. Pediatr. Nephrol. 2000, 15, 279-285.
32. Nerlich, A., Morphology of basement membrane and associated matrix proteins in normal and pathological tissues. Veroffentlichungen aus der Pathologie 1995, 145, 1-139.
33. Miner, J. H., Sanes, J. R., Molecular and functional defects in kidneys of mice lacking collagen alpha 3(IV): implications for Alport syndrome. J. Cell Biol. 1996, 135, 1403-1413.
34. Mishra, R., Emancipator, S. N., Kern, T., Simonson, M. S., High glucose evokes an intrinsic proapoptotic signaling pathway in mesangial cells. Kidney Int. 2005, 67, 82-93. (Pubitemid 40019229)
35. Verzola, D., Gandolfo, M. T., Ferrario, F., Rastaldi, M. P. et al., Apoptosis in the kidneys of patients with type II diabetic nephropathy. Kidney Int. 2007, 72, 1262-1272. (Pubitemid 350059668)
36. Abu-Hamad, S., Sivan, S., Shoshan-Barmatz, V., The expression level of the voltage-dependent anion channel controls life and death of the cell. Proc. Natl. Acad. Sci. USA 2006, 103, 5787-5792.
37. Turko, I. V., Murad, F., Quantitative protein profiling in heart mitochondria from diabetic rats. J. Biol. Chem. 2003, 278, 35844-35849. (Pubitemid 37102363)
38. Cooper, G. J., Phillips, A. R., Choong, S. Y., Leonard, B. L. et al., Regeneration of the heart in diabetes by selective copper chelation. Diabetes 2004, 53, 2501-2508.
39. Cooper, G. J., Young, A. A., Gamble, G. D., Occleshaw, C. J. et al., A copper(II)-selective chelator ameliorates left-ventricular hypertrophy in type-2 diabetic patients. Diabetologia 2009, 52, 715-722.
40. Cooper, G. J., Chan, Y. K., Dissanayake, A. M., Leahy, F. E. et al., Demonstration of a hyperglycemia-driven pathogenic abnormality of copper homeostasis in diabetes and its reversibility by selective chelation: quantitative comparisons between the biology of copper and eight other nutritionally essential elements in normal and diabetic individuals. Diabetes 2005, 54, 1468-1476.